BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25443193)

  • 1. [SD-OCT As screening test for hydroxychloroquine retinopathy: The «flying saucer» sign].
    Asensio-Sánchez VM
    Arch Soc Esp Oftalmol; 2015 Jul; 90(7):338-40. PubMed ID: 25443193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
    Ahn SJ; Ryu SJ; Lim HW; Lee BR
    Retina; 2019 May; 39(5):1016-1026. PubMed ID: 29373341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathy.
    Kelmenson AT; Brar VS; Murthy RK; Chalam KV
    Eur J Ophthalmol; 2010; 20(4):785-8. PubMed ID: 20099229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine.
    Chiang E; Jampol LM; Fawzi AA
    Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940
    [No Abstract]   [Full Text] [Related]  

  • 7. Signs of hydroxychloroquine toxicity in a patient with rhegmatogenous retinal detachment.
    Campos-Pavón J; Sambricio J; Redondo-García I
    Arch Soc Esp Oftalmol; 2016 Sep; 91(9):450-2. PubMed ID: 27005921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Telek HH; Yesilirmak N; Sungur G; Ozdemir Y; Yesil NK; Ornek F
    Doc Ophthalmol; 2017 Dec; 135(3):187-194. PubMed ID: 28852896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The flying saucer sign in toxic hydroxychloroquine retinopathy].
    Zone Abid I; Kaibi I; Turki R; Gargouri S; Feki J
    J Fr Ophtalmol; 2019 May; 42(5):542-543. PubMed ID: 30962067
    [No Abstract]   [Full Text] [Related]  

  • 10. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M; Chan EW; Omar A
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of Microperimetry in Detecting Early Retinal Toxicity of Hydroxychloroquine in Children with Juvenile Systemic Lupus Erythematosus.
    Youssef MM; El-Fayoumi D; Sidky MK; Hegazy AI; Marzouk H; Eltanamly RM
    Ophthalmologica; 2017; 237(3):180-184. PubMed ID: 28297699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
    Chew AL; Sampson DM; Chelva E; Khan JC; Chen FK
    Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of parafoveal cone density in patients taking hydroxychloroquine in the absence of clinically documented retinal toxicity.
    Debellemanière G; Flores M; Tumahai P; Meillat M; Bidaut Garnier M; Delbosc B; Saleh M
    Acta Ophthalmol; 2015 Nov; 93(7):e534-40. PubMed ID: 25989823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral-Domain Optical Coherence Tomography Is More Sensitive for Hydroxychloroquine-Related Structural Abnormalities Than Short-Wavelength and Near-Infrared Autofluorescence.
    Jauregui R; Parmann R; Nuzbrokh Y; Tsang SH; Sparrow JR
    Transl Vis Sci Technol; 2020 Aug; 9(9):8. PubMed ID: 32879764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine retinopathy: an emerging problem.
    Latasiewicz M; Gourier H; Yusuf IH; Luqmani R; Sharma SM; Downes SM
    Eye (Lond); 2017 Jun; 31(6):972-976. PubMed ID: 28186509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report.
    Hong EH; Ahn SJ; Lim HW; Lee BR
    BMC Ophthalmol; 2017 Jul; 17(1):124. PubMed ID: 28701214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.